Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis.
Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
IL-4/10 prevents stress vulnerability following imipramine discontinuation.
Functional plasticity of the visual system in multiple sclerosis.
Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
Assessing spinal cord function in multiple sclerosis with functional neuroimaging: insights and limitations.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
Improving Safety and Operational Efficiency in Residential Care Settings With WiFi-Based Localization.
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
The role of epidemiology in MS research: Past successes, current challenges and future potential.
Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
Erratum to: Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Dalfampridine prior authorization program: a cohort study.
Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
Diagnosis and differential diagnosis of multiple sclerosis.
Balance.
Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
Identifying and treating pain caused by MS.
Heat sensitive persons with multiple sclerosis are more tolerant to resistance exercise than to endurance exercise.
Comparison of Magnetic Susceptibility Tensor and Diffusion Tensor of the Brain.
Pages
« first
‹ previous
…
288
289
290
291
292
293
294
295
296
…
next ›
last »